PT Kimia Farma Tbk (IDX:KAEF)

Market Cap	2.98T
Revenue (ttm)	9.57T
Net Income (ttm)	-841.72B
Shares Out	5.57B
EPS (ttm)	-151.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,031,500
Average Volume	2,948,650
Open	540.00
Previous Close	540.00
Day's Range	525.00 - 545.00
52-Week Range	324.00 - 905.00
Beta	1.47
RSI	43.73
Earnings Date	Aug 14, 2025

About PT Kimia Farma Tbk

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia, Saudi Arabia, the United States, the Netherlands, the United Kingdom, China, Malaysia, and internationally. The company operates through the Manufacturing, Distribution, Retail, and Other segments. It provides generic, ethical, licensed, and narcotic medicines; over-the-counter medicines and herbs; tablets, injections, syrups, raw materials, medical devices, and cosmetic products. The company is also involved in research and development activities,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 5,946
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2024, PT Kimia Farma Tbk's revenue was 9.94 trillion, an increase of 0.68% compared to the previous year's 9.87 trillion. Losses were -842.27 billion, -57.12% less than in 2023.